Shionogi Launches ARB/Diuretic Combination In Japan
This article was originally published in PharmAsia News
In Japan, Shionogi launched Irtra, a combination of Irbetan (irbesartan) and the diuretic Fluitran (trichlormethiazide), the company announced Sept. 4.
You may also be interested in...
With Roche's oral spinal muscular atrophy therapy Evrysdi off to a strong start after its recent US launch, Novartis is switching its priorities for rival RNA-splicing drug branaplam and putting it into a Phase IIb trial for Huntington's disease.
Nuvation started in 2018 and raised a $275m series A round in 2019. Now it is merging with the EcoR1 Capital-sponsored SPAC Panacea Acquisition Corp. and raising $500m in equity capital.
US FDA investigators' increased focus on aseptic operations is resulting in more Form 483 observations of microbiological contamination issues over the past few years.